[HTML][HTML] Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study

KS Cheung, EW Chan, AYS Wong, L Chen, ICK Wong… - Gut, 2018 - gut.bmj.com
Objective Proton pump inhibitors (PPIs) is associated with worsening of gastric atrophy,
particularly in Helicobacter pylori (HP)-infected subjects. We determined the association …

Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.

KS Cheung, EW Chan, A Wong, L Chen… - Gut, 2017 - researchonline.lshtm.ac.uk
OBJECTIVE: Proton pump inhibitors (PPIs) is associated with worsening of gastric atrophy,
particularly in Helicobacter pylori (HP)-infected subjects. We determined the association …

Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study

KS Cheung, EW Chan, AYS Wong, L Chen, ICK Wong… - Gut, 2018 - discovery.ucl.ac.uk
Objective: Proton pump inhibitors (PPIs) is associated with worsening of gastric atrophy,
particularly in Helicobacter pylori (HP)-infected subjects. We determined the association …

Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: A population-based study

KSM Cheung, EW Chan, YS Wong, L Chen, ICK Wong… - Gut, 2018 - hub.hku.hk
Objective: Proton pump inhibitors (PPIs) is associated with worsening of gastric atrophy,
particularly in Helicobacter pylori (HP)-infected subjects. We determined the association …

Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study.

KS Cheung, EW Chan, AYS Wong, L Chen, ICK Wong… - Gut, 2017 - europepmc.org
Objective Proton pump inhibitors (PPIs) is associated with worsening of gastric atrophy,
particularly in Helicobacter pylori (HP)-infected subjects. We determined the association …

Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study

KS Cheung, EW Chan, AYS Wong, L Chen, ICK Wong… - Gut, 2018 - search.proquest.com
Objective Proton pump inhibitors (PPIs) is associated with worsening of gastric atrophy,
particularly in Helicobacter pylori (HP)-infected subjects. We determined the association …

[PDF][PDF] Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study

WK Leung - Gut, 2018 - scholar.archive.org
AbstrAct Objective Proton pump inhibitors (PPIs) is associated with worsening of gastric
atrophy, particularly in Helicobacter pylori (HP)-infected subjects. We determined the …

Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study

KS Cheung, EW Chan, AYS Wong, L Chen… - Gut, 2018 - pubmed.ncbi.nlm.nih.gov
Objective Proton pump inhibitors (PPIs) is associated with worsening of gastric atrophy,
particularly in Helicobacter pylori (HP)-infected subjects. We determined the association …

[PDF][PDF] LONG-TERM PROTON PUMP INHIBITORS AND RISK OF GASTRIC

KS Cheung, EW Chan, AYS Wong - 116683.com
ABSTRACT 1 Objective: Proton pump inhibitors (PPIs) is associated with worsening of
gastric 2 atrophy, particularly in H. pylori (HP)-infected subjects. We determined the 3 …

Long-term proton pump inhibitors and risk of gastric cancer development after treatment for Helicobacter pylori: a population-based study

KS Cheung, EW Chan, AYS Wong, L Chen, ICK Wong… - Gut, 2018 - gut.bmj.com
Objective Proton pump inhibitors (PPIs) is associated with worsening of gastric atrophy,
particularly in Helicobacter pylori (HP)-infected subjects. We determined the association …